2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3012
  



  

  
Submitter : 
  

  
Ms. Christine Vayo
  

  
Date & Time: 
  

  
12/12/2006 09:12:01
  



  

  
Organization : 
  

  
Ms. Christine Vayo
  



  

  
Category : 
  

  
Other Government
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 [2006D0383] There are a number of cell lines which have originated from 

ethical and completely non-controversial sources for the development of 

vaccines. I support the FDA recommending that pharmaceutical companies use 

these cells from non-controversial sources instead of cells derived from 

aborted children.